Christophe Van Vaeck

About

Christophe Van Vaeck (°1973) earned his PhD in Biology at the lab of Molecular and Cellular Biology at the K.U.Leuven (Belgium) in 2000. He then switched to the financial world and worked as a financial analyst Life Sciences at KBC Securities, where he guided the Euronext IPOs of Galapagos, deVGen, Thrombogenics and Ablynx. In 2008, he joined Gimv as senior investment manager. Christophe is a board observer at Multiplicom and is actively involved in the portfolio management of Ceres, Vitromics, Jenavalve and Endosense and the Gimv-Agri+ Investment Fund.

Investment Focus

Location

Leuven, Belgium